Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,904 | -22,629 | -19,832 | -10,122 | -12,519 |
| Depreciation Amortization | 1,216 | 1,178 | 939 | 211 | 187 |
| Accounts receivable | 188 | -216 | -7 | 231 | N/A |
| Other Working Capital | -2,195 | 1,534 | -13 | -178 | 1,064 |
| Other Operating Activity | 2,763 | 8,425 | 8,321 | 1,380 | 3,171 |
| Operating Cash Flow | $-18,932 | $-11,707 | $-10,592 | $-8,478 | $-8,097 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,490 | -15,008 | N/A | N/A | N/A |
| PPE Investments | -176 | -208 | -125 | -39 | -196 |
| Other Investing Activity | -67 | -348 | -412 | -216 | -285 |
| Investing Cash Flow | $7,246 | $-15,564 | $-537 | $-255 | $-481 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,213 | 7,551 | N/A | N/A |
| Debt Repayment | -1,154 | -1,929 | N/A | N/A | N/A |
| Common Stock Issued | 6,006 | 21,263 | 13,157 | 13,889 | 1,668 |
| Other Financing Activity | -964 | -602 | -183 | -65 | 0 |
| Financing Cash Flow | $3,887 | $22,944 | $20,525 | $13,824 | $1,668 |
| Exchange Rate Effect | -4 | -1 | 6 | 0 | N/A |
| Beginning Cash Position | 12,519 | 16,846 | 7,444 | 2,352 | 9,261 |
| End Cash Position | 4,717 | 12,519 | 16,846 | 7,444 | 2,352 |
| Net Cash Flow | $-7,802 | $-4,327 | $9,402 | $5,092 | $-6,909 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,932 | -11,707 | -10,592 | -8,478 | -8,097 |
| Capital Expenditure | -176 | -208 | -125 | -39 | -196 |
| Free Cash Flow | -19,108 | -11,915 | -10,717 | -8,517 | -8,293 |